KEGG   PATHWAY: ocu05213
Entry
ocu05213                    Pathway                                
Name
Endometrial cancer - Oryctolagus cuniculus (rabbit)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
ocu05213  Endometrial cancer
ocu05213

Organism
Oryctolagus cuniculus (rabbit) [GN:ocu]
Gene
100008808  pro-epidermal growth factor [KO:K04357]
100008806  epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
100348663  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100345181  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
100337822  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100357841  phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100345250  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
100358716  phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
100347954  3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
100355759  integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
100342852  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100353706  RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
127486116  RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100101592  caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
100358587  bcl2-associated agonist of cell death [KO:K02158]
100343573  forkhead box protein O3 [KO:K09408]
100342500  growth factor receptor-bound protein 2 [KO:K04364]
100356615  son of sevenless homolog 1 isoform X1 [KO:K03099]
100346391  son of sevenless homolog 2 isoform X1 [KO:K03099]
127486605  GTPase HRas isoform X1 [KO:K02833]
100347487  GTPase KRas isoform X1 [KO:K07827]
127489236  GTPase KRas-like [KO:K07827]
100344241  GTPase NRas [KO:K07828]
100340437  serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100351964  serine/threonine-protein kinase B-raf isoform X6 [KO:K04365] [EC:2.7.11.1]
100347407  RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100009316  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
127489461  LOW QUALITY PROTEIN: dual specificity mitogen-activated protein kinase kinase 1-like [KO:K04368] [EC:2.7.12.2]
100347345  mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100348561  mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100340952  ETS domain-containing protein Elk-1 [KO:K04375]
100337912  DNA mismatch repair protein Mlh1 isoform X2 [KO:K08734]
100356548  cadherin-1 [KO:K05689]
100125985  catenin beta-1 [KO:K02105]
100343241  catenin alpha-3 isoform X1 [KO:K05691]
100328952  CTNNA1; catenin alpha-1 [KO:K05691]
100352391  catenin alpha-2 isoform X1 [KO:K05691]
100348127  axin-1 isoform X1 [KO:K02157]
100339765  axin-2 [KO:K04385]
100353976  adenomatous polyposis coli protein isoform X1 [KO:K02085]
103346018  LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085]
127485674  adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
100348842  glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
100339216  transcription factor 7 isoform X1 [KO:K02620]
100340471  transcription factor 7-like 1 isoform X1 [KO:K04490]
100358378  transcription factor 7-like 2 isoform X1 [KO:K04491]
100352691  lymphoid enhancer-binding factor 1 isoform X2 [KO:K04492]
100327265  MYC; myc proto-oncogene protein [KO:K04377]
100009292  TP53; cellular tumor antigen p53 [KO:K04451]
100348489  cyclin-dependent kinase inhibitor 1 [KO:K06625]
100353284  growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
100353742  growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
100355675  apoptosis regulator BAX isoform X2 [KO:K02159]
100342046  bcl-2 homologous antagonist/killer [KO:K14021]
100352386  DNA damage-binding protein 2 [KO:K10140]
100352218  DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
100009554  receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
ocu04010  MAPK signaling pathway
ocu04012  ErbB signaling pathway
ocu04060  Cytokine-cytokine receptor interaction
ocu04110  Cell cycle
ocu04115  p53 signaling pathway
ocu04151  PI3K-Akt signaling pathway
ocu04310  Wnt signaling pathway
ocu04520  Adherens junction
KO pathway
ko05213   
LinkDB

DBGET integrated database retrieval system